CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K / AKT pathway
Thoracic Cancer · 2023
DOI: 10.1111/1759-7714.14800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Sitong Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Commission of Health.
Abstract (Originalsprache)
Background
Lung adenocarcinomas (LUAD) remain the leading cause of death in many countries. In this study, we investigated the role of division cycle‐associated 4 (CDCA4) in the carcinogenesis of LUADs.
Methods
Real‐time fluorescent quantitative polymerase chain reaction and western blot were performed to detect the messenger RNA and protein levels of CDCA4 in cells. Cell counting kit 8, real‐time cell analysis, clone formation, EdU assays, and cell‐cycle assays were used to preliminarily investigate the proliferation and cell‐cycle–related functions of CDCA4 in lung adenocarcinoma. Immunoprecipitation assays were used to identify possible targets of CDCA4. A xenograft model was used to examine how CDCA4 knockdown affects LUAD cells growth in vivo.
Results
We found that the expression of CDCA4 was upregulated in LUAD cell lines. When CDCA4 was knocked out, the ability of LUAD cells to proliferate was dramatically reduced, and the cell cycle was stalled in the S phase. Meanwhile, boosting the CDCA4 expression had the opposite effect. The critical protein levels of phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) signaling pathway were subsequently examined. The findings demonstrated that elevated CDCA4 lowered the phosphate and tensin homolog expression and increased the p‐PI3K and p‐AKT levels. Moreover, we demonstrated that CDCA4 favorably regulated IGF2BP1, a downstream target. The downregulation of the IGF2BP1 expression could reverse the proliferation promotion effect induced by the CDCA4 overexpression.
Conclusions
CDCA4 can operate as an oncogenic factor to control the growth of lung adenocarcinoma via the PI3K/AKT pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
- Research Center for Clinical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Jifeng Feng
Förderung
- Jiangsu Commission of Health
Zitieren
APA
Feng, S., Cao, H., Sui, Y., Shen, Z., Wu, J., Ma, R., & Feng, J. (2023). CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K / AKT pathway. Thoracic Cancer. https://doi.org/10.1111/1759-7714.14800
Vancouver
Feng S, Cao H, Sui Y, Shen Z, Wu J, Ma R, et al. CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K / AKT pathway. Thoracic Cancer. 2023. doi:10.1111/1759-7714.14800
BibTeX
@article{Feng2023,
author = {Feng, Sitong and Cao, Haixia and Sui, Ying and Shen, Ziyang and Wu, Jianzhong and Ma, Rong and Feng, Jifeng},
title = {CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K / AKT pathway},
journal = {Thoracic Cancer},
year = {2023},
doi = {10.1111/1759-7714.14800}
}
EUVIMED